What is Canaloplasty? (Kamat, MD, USA) скачать в хорошем качестве

What is Canaloplasty? (Kamat, MD, USA)

In this roundtable discussion from the Interventional Glaucoma Consortium (IGC) 2024, Shivani Kamat, MD, reviews the canaloplasty procedure, discusses the importance of early intervention in glaucoma treatment, and describes how she consults and educates patients about their treatment options. Importantly, she addresses the multi-modal mechanism of action of canaloplasty. which is designed to target and treat the trabecular meshwork, Schlemm’s canal and the collector channels. The iTrack™ Advance has a US Food and Drug Administration (FDA) 510(k) and CE Mark (Conformité Européenne) for the treatment of open-angle glaucoma. Indications for Use, USA: The iTrack™ Advance is indicated for fluid infusion or aspiration during surgery. The iTrack™ Advance is indicated for the cutting or disruption of the trabecular meshwork during goniotomy procedures.* The iTrack™ Advance is indicated for catheterization and viscodilation of Schlemm’s canal to reduce intraocular pressure in adult patients with open-angle glaucoma. The ab interno surgical technique is not a cleared indication for the iTrack™ Advance in the USA. The iTrack™ Advance cutting function (goniotomy) is a Class 1 510(k) exempt device function that is not specifically indicated for the reduction of intraocular pressure (IOP) or the treatment of open-angle glaucoma. Indications for Use, International: The iTrack™ Advance is indicated for fluid infusion or aspiration during surgery. The iTrack™ Advance is indicated for catheterization and viscodilation of Schlemm’s canal to reduce intraocular pressure in adult patients with open-angle glaucoma. For more information in relation to approved labelling and indications for use, please visit https://itrack-advance.com/